Rethinking Antibiotic Resistance Through Engineered Biology
At Boston University’s Biological Design Center, researchers are rethinking how engineering biology can illuminate—and ultimately help solve—some of today’s most pressing challenges.
WHO Joins Forces with BU Center on Forced Displacement to Help Vulnerable Populations at Risk of Antimicrobial Resistance
Collaboration will study link between environmental pollution and drug-resistant infections among refugees and asylum seekers
Big Majority of Young Adults Are Pro-COVID Vaccine, Driven to Protect Themselves and Community, BU Study Finds
Boston University researchers also find those with anti-vaccine attitudes are less altruistic, more likely to distrust science and government
WHO Reports 40 Percent Jump in Antibiotic-Resistant infections; BU-Based Nonprofit Leads the Fight Back
CARB-X, an antibiotics research accelerator, is helping bring new medicines, vaccines, and tests to clinics worldwide
From Better Batteries to Improved Cartilage Repair, BU Ignition Award Winners Aim for Real-World Impact
Annual honors support innovative Boston University research projects preparing to leap from lab to commercialization
Testing a New Approach to Solving the Opioid Epidemic
Biochemistry undergraduate Sarah Kornfeld explains BU research that could one day help treat pain without the fear of addiction
BU Autism Expert Says Research Hasn’t Confirmed Tylenol Link
White House had urged pregnant women to avoid the pain medicine acetaminophen for themselves, children.
Boston University, Boston Medical Center Researchers Work with High School Students to Build Peer-Led Overdose Prevention Program
Building a curriculum for teens, by teens: students from a Roxbury school met with researchers all summer to learn about opioid overdose prevention
What Are PFAS? And Could Fiber Supplements Help Remove Them from Our Bodies?
BU study suggests common dietary supplement could decrease levels of the forever chemicals.
Renowned Virologist Robert A. Davey to Lead NEIDL
An expert on virus-host interactions and antiviral drug discovery, Davey says NEIDL will continue to focus on conducting “creative, inventive science in the safest ways possible”.